⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

January 1, 2021International Journal of Medical SciencesOpen Access

Immune checkpoint molecules are regulated by transforming growth factor (TGF)-β1-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

1-mediated EMT and regulation of immune checkpoints in HCC.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Shrestha et al. (2021) studied this question.

synapsesocial.com/papers/6a087dc77de338f10b10b9bb https://doi.org/10.7150/ijms.54239

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization ApproachOriginal Research · 2015 · 43 citations
2Epithelial-to-Mesenchymal Transition: A Mediator of Sorafenib Resistance in Advanced Hepatocellular CarcinomaReview · 2017 · 77 citations
3Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinomaCase Report · 2019 · 168 citations
4Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathwayOriginal Research · 2019 · 220 citations